Sigma-Aldrich Corporation  

(Public, NASDAQ:SIAL)   Watch this stock  
Find more results for George Bertsch�
135.11
+0.20 (0.15%)
Real-time:   2:58PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 134.83 - 135.45
52 week 83.75 - 138.01
Open 134.83
Vol / Avg. 454,944.00/1.70M
Mkt cap 16.08B
P/E 32.63
Div/yield 0.23/0.68
EPS 4.14
Shares 119.00M
Beta 0.89
Inst. own 83%
Oct 23, 2014
Q3 2014 Sigma-Aldrich Corporation Earnings Release
Sep 22, 2014
Merck KGaA to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry Analysts & Investors Call
Sep 22, 2014
Merck KGaA to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry Media Call
Sep 9, 2014
Sigma-Aldrich Corp at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 15.65% 18.16%
Operating margin 22.32% 24.45%
EBITD margin - 30.36%
Return on average assets 10.86% 12.88%
Return on average equity 14.01% 18.05%
Employees 9,000 -
CDP Score - 97 B

Address

3050 Spruce Street
ST. LOUIS, MO 63103
United States - Map
+1-314-7715765 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services. These chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. As of December 31, 2012, the Company offered approximately 45,000 equipment products. On January 31, 2012, the Company completed its acquisition of all of interest of BioReliance, a provider of global biopharmaceutical testing services. On April 2, 2012, the Company acquired Research Organics, a supplier of purity biochemicals.

Officers and directors

Barrett A. Toan Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Rakesh Sachdev President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Jan A. Bertsch Chief Financial Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Gilles A. Cottier Executive Vice President, President - SAFC Commercial
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Eric Mark Green Executive Vice President; President - Research
Age: 44
Bio & Compensation  - Reuters
Franklin D. Wicks Jr. Executive Vice President; President - Applied
Age: 60
Bio & Compensation  - Reuters
George Lloyd Miller Senior Vice President, General Counsel, Secretary
Age: 59
Bio & Compensation  - Reuters
Karen J. Miller Senior Vice President - Corporate Development and Corporate Communications
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Kanan Vice President, Corporate Controller
Age: 50
Bio & Compensation  - Reuters
Michael Hollenkamp Vice President, Treasurer
Bio & Compensation  - Reuters